EDIT Editas Medicine, Inc.
Healthcare$3.08+11.59%ClosedMarket Cap: $301.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
61.29
P/S
6.98
EV/EBITDA
-2.16
DCF Value
$-5.21
FCF Yield
-52.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
98.8%
Operating Margin
-297.5%
Net Margin
-281.6%
ROE
-677.4%
ROA
-73.0%
ROIC
-93.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.8M | 82.9% | $-25.0M | $-25.0M | $— | — |
| Q4 null | $24.7M | 100.0% | $-14.0M | $-5.6M | $— | — |
| FY null | $40.5M | 100.0% | $-99.3M | $-160.1M | $— | — |
| Q3 null | $7.5M | 100.0% | $-24.5M | $-25.1M | $— | — |
| Q2 null | $3.6M | 100.0% | $-51.5M | $-53.2M | $— | — |
| Q1 null | $4.7M | 100.0% | $-76.2M | $-76.1M | $— | — |
| Q4 null | $30.6M | 100.0% | $-46.6M | $-45.4M | $— | — |
| FY null | $32.3M | 100.0% | $-251.2M | $-237.1M | $— | — |
| Q3 null | $61.0K | -2521.3% | $-65.7M | $-62.1M | $— | — |
| Q2 null | $513.0K | -176.8% | $-71.9M | $-67.6M | $— | — |
| Q1 null | $1.1M | -24.1% | $-67.0M | $-62.0M | $— | — |
| Q4 2023 | $60.0M | 97.6% | $-24.0M | $-18.9M | $-0.23 | — |